The effect of hyperglycemia and hypoglycemia on glucose transport and expression of glucose transporters in human lymphocytes B and T: An in vitro study

Diabetes Research and Clinical Practice

Volumn 96, Issue 2, 2012, Pages 170-178

  Oleszczak, Bozenna ^a   Szablewski, Leszek ^a   Pliszka, Monika ^a  

^a MEDICAL UNIVERSITY OF WARSAW   (Poland)

Author keywords

Deoxy d glucose; Glucose transporters; Hyperglycemia; Hypoglycemia; Lymphocytes B and T

Indexed keywords

DEOXYGLUCOSE; GLUCOSE; GLUCOSE TRANSPORTER 1; GLUCOSE TRANSPORTER 3; GLUCOSE TRANSPORTER 4; TRITIUM;

ADULT; ARTICLE; B LYMPHOCYTE; BLOOD SAMPLING; CELL ISOLATION; CELL MEMBRANE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; FEMALE; FLOW CYTOMETRY; GLUCOSE TRANSPORT; HUMAN; HUMAN CELL; HUMAN EXPERIMENT; HYPERGLYCEMIA; HYPOGLYCEMIA; IN VITRO STUDY; MALE; NORMAL HUMAN; PROTEIN EXPRESSION; T LYMPHOCYTE;

ADULT; B-LYMPHOCYTES; BIOLOGICAL TRANSPORT; DEOXYGLUCOSE; FEMALE; FLOW CYTOMETRY; GLUCOSE; GLUCOSE TRANSPORT PROTEINS, FACILITATIVE; HUMANS; HYPERGLYCEMIA; HYPOGLYCEMIA; MALE; T-LYMPHOCYTES;

EID: 84860534699     PISSN: 01688227     EISSN: 18728227     Source Type: Journal    
DOI: 10.1016/j.diabres.2011.12.012     Document Type: Article

References (50)

1. Angele M.K., Chaudry I.H. Surgical trauma and immunosuppression: pathophysiology and potential immunomodulatory approaches. Langenbecks Arch Surg 2005, 390:333-341.
2. Morgan T.E., Wong A.M., Finch C.E. Anti-inflammatory mechanism of dietary restriction in slowing processes. Interdiscip Top Gerontol 2007, 35:83-97.
3. Franceschi C. Inflammaging as a major characteristic of old people; can it be prevented or cured?. Nutr Rev 2007, 65(12 Pt 2):S173-S176.
4. Vasto S., Candore G., Balistreri C.R., Caruso M., Colonna-Romano G., Grimaldi M.P., et al. Inflammatory networks in ageing, age-related diseases and longevity. Mech Ageing Dev 2007, 128:83-91.
5. MacIver N.J., Jacobs S.R., Wieman H.L., Wofford J.A., Coloff J.L., Rathmell J.C. Glucose metabolism in lymphocytes is a regulated process with significant effects on immune cell function and survival. J Leukoc Biol 2008, 81:919-937.
6. Devrajani B.R., Sli Shah S.Z., Soomro A.A., Devrajani T. Type 2 diabetes mellitus: a risk factor for Helicobacter pylori infection: a hospital based case-control study. Int J Diab Dev Countries 2010, 30:22-26.
7. Rahman A., Cope M.B., Sarker S.A., Garvey W.T., Chaundry H.S., Khaled M.A. Helicobacter pylori infection and inflammation: implications for pathophysiology of diabetes mellitus and coronary heart disease. J Life Sci 2009, 1:45-50.
8. Heymann A.D., Chodick G., Karpati T., Kamer L., Kremer E., Green M.S., et al. Diabetes as a risk factor for herpes zoster infection: results of a population-based study in Israel. Infection 2008, 36:226-230.
9. Fu Y., Maianu L., Melbert B.R., Garvey W.T. Facilitative glucose transporter gene expression in human lymphocytes, monocytes, and macrophages: a role for GLUT isoforms 1, 3, and 5 in the immune response and foam cell formation. Blood Cells Mol Dis 2004, 32:182-190.
10. Otton R., Mendonca J.R., Curie R. Diabetes causes marked changes in lymphocyte metabolism. J Endocrinol 2002, 174:55-61.
11. Szablewski L., Oleszczak B., Mrozikiewicz-Rakowska B., Karnafel W., Grytner-Ziecina B. Deoxy-d-glucose transport into lymphocytes, granulocytes and erythrocytes in patients with type 2 diabetes mellitus. Exp Clin Diabetol 2007, 7:245-255.
12. Mostert M., Rabbone I., Piccinini M., Curto M., Vai S., Musso A., et al. Derangements of pyruvate dehydrogenase in circulating lymphocytes of NIDDM patients and their healthy offspring. J Endocrinol Invest 1999, 22:519-526.
13. Rinaudo M.T., Curto M., Rabbone I., Piccinini M., Bruno R., Mioletti S., et al. Effect of sulfonylurea agents on pyruvate dehydrogenase activity in circulating lymphocytes from patients with non-insulin-dependent diabetes mellitus (NIDDM). J Diabetes Complications 1994, 8:221-225.
14. Szablewski L. Disturbances of cellular transport of deoxy-D-glucose into selected peripheral blood cells in patients with type 2 diabetes. The effect of illness and mode of therapy on glucose transporters in blood cells 2006, [in Polish]. A.M. Warsaw (Ed.).
15. Szablewski L., Sobczyk-Kopcioł A., Oleszczak B., Mrozikiewicz-Rakowska B., Karnafel W., Grytner-Ziecina B. Expression of glucose transporters in peripheral blood cells in patients with type 2 diabetes mellitus depending on the mode of therapy. Exp Clin Diabetol 2007, 7:204-212.
16. Chen L.A. A literature review of intensive insulin therapy and mortality in clinically ill patients. Clin Nurse Spec 2010, 24:80-86.
17. Ito T., Otsuki M., Igarashi H., Kihara Y., Kawabe T., Nakamura T., et al. Epidemiological study of pancreatic diabetes in Japan in 2005: a nationwide study. Pancreas 2010, 39:829-835.
18. Swinnen S.G., Dain M.P., Aronson M., Davies M., Gerstein H.C., Pfeiffer A.F., et al. A 24-week randomized, treat-to-target trial comparing initiation of insulin glargine once-daily with insulin detemir twice-daily in patients with type 2 diabetes inadequately controlled on oral glucose-lowering drugs. Diabetes Care 2010, 33:1176-1178.
19. Chen S.L., Jackson S.L., Boyko E.J. Diabetes mellitus and urinary tract infection: epidemiology, pathogenesis and proposed studies in animal models. J Urol 2009, 182(Suppl. 6):S51-S56.
20. Ducluzeau P.-H., Perretti N., Laville M., Andreelli F., Vega N., Riou J.P., et al. Regulation by insulin of gene expression in human skeletal muscle and adipose tissue: evidence for specific defects in type 2 diabetes. Diabetes 2001, 50:1134-1142.
21. Krook A., Bjornholm M., Galuska D., Jiang X.J., Fahlman R., Myers M.G., et al. Characterization of signal transduction and glucose transport in skeletal muscle from type 2 diabetic patients. Diabetes 2000, 49:284-292.
22. Joost H.G., Mueckler M., Bell G.I., Best J.D., Birnbaum M.J., Charron M.J., et al. Nomenclature of GLUT/SLC2A family of a sugar/polyol transport facilitators. Am. J Physiol 2002, 282:E974-E1076.
23. Maratou E., Dimitriadis G., Kollias A., Boutati E., Lambadiari V., Mitrou P., et al. Glucose transporter expression on the plasma membrane of resting cells and activated blood cells. Eur J Clin Invest 2007, 37:282-290.
24. Szablewski L., Sobczyk-Kopcioł A., Oleszczak B., Nowak Ł., Grytner-Ziecina B. GLUT 4 is expressed in circulating lymphocytes of diabetic patients. A method to detect early prediabetic stages?. Diabetologia Croatica 2007, 36:69-76.
25. Li H., Gu Y., Zhang Y., Lucas M.J., Wang Y. High glucose levels down-regulate glucose transporter expression that correlates with increased oxidative stress in placental trophoblast cells in vitro. J Soc Gynecol Investig 2004, 11:75-81.
26. Korgun E.T., Demir R., Sedlmayr P., Desoye G., Arikan G.M., Puerstner P., et al. Sustained hypoglycemia affects glucose transporter expression of human blood leukocytes. Blood Cells Mol Dis 2002, 28:152-159.
27. Simpson I.A., Dwyer D., Malide D., Moley K.H., Travis A., Vanucci S.J. The facilitative glucose transporter GLUT3: 20 years of distinction. Am J Physiol Endocrinol Metab 2008, 295:E242-E253.
28. Thorens B., Mueckler M. Glucose transporters in the 21st century. Am J Physiol Endocrinol Metab 2010, 298:E141-E145.
29. Kobayashi C., Sasaki H., Kosuge K., Miyakita Y., Hayakawa M., Suzuki A., et al. Severe starvation hypoglycemia and congestive heart failure induced by thyroid crisis, with accidentally induced severe liver dysfunction and disseminated intravascular coagulation. Intern Med 2005, 44:234-239.
30. Bolinder J., Sjöberg S., Arner P. Stimulation of adipose tissue lipolysis following insulin-induced hypoglycaemia: evidence of increased beta-adrenoreceptor-mediated lipolytic response in IDDM. Diabetologia 1996, 39:845-853.
31. Chon S., Choi M.C., Lee Y.J., Hwang Y.C., Jeong I.K., Oh S., et al. Autoimmune hypoglycemia in a patient with characterization of insulin receptor autoantibodies. Diabetes Metab J 2011, 35:80-85.
32. Halsaal D.J., Mangi M., Soos M., Fahie-Wilson M.N., Wark G., Mainwaring-Burton R., et al. Hypoglycemia due to an insulin binding antibody in a patient with an IgA-κ myeloma. J Clin Endocrinol Metab 2007, 92:2013-2016.
33. Otton R., Soriano F.G., Verlengia R., Curi R. Diabetes induces apoptosis in lymphocytes. J Endocrinol 2004, 182:145-156.
34. Kitabchi A.E., Stentz F.B., Umpierrez G.E. Diabetic ketoacidosis induces in vivo activation of human T-lymphocytes. Biochem Biophys Res Commun 2004, 315:404-407.
35. Hanazaki K., Maeda H., Okabayashi T. Relationship between perioperative glycemic control and postoperative infections. World J Gastroenterol 2009, 15:4122-4125.
36. Palmeira C.M., Rolo A.P., Berthiaume J., Bjork J.A., Wallace K.B. Hyperglycemia decreases mitochondrial function: the regulatory role of mitochondrial biogenesis. Toxicol Appl Pharmacol 2007, 225:214-220.
37. Kaliman P., Viñals F., Testar X., Palacin M., Zorzano A. Disruption of GLUT1 glucose carrier trafficking in L6E9 and Sol8 myoblasts by the phosphatidylinositol 3-kinase inhibitor wortmannin. Biochem J 1995, 312:471-477.
38. Hosaka T., Yaga K., Oka Y. Regulation of insulin-stimulated glucose transport by chronic glucose exposure in 3T3-L1 adipocytes. Endocr J 1999, 46:349-357.
39. Katagiri H., Asano T., Ishihara H., Inukai K., Shibasaki Y., Kikuchi M., et al. Overexpression of catalytic subunit p110a of phosphatidylinositol 3-kinase increases glucose transport activity with translocation of glucose transporters in 3T3-L1 adipocytes. J Biol Chem 1996, 271:16987-16990.
40. 18F-FDG uptake. J Nucl Med 2004, 45:930-932.
41. Takanaga H., Chaudhuri B., Frommem W.B. GLUT1 and GLUT9 as the major contributors to glucose influx in HEPG2 cells identified by a high sensitivity intramolecular FRET glucose sensor. Biochim Biophys Acta 2008, 1778:1091-1099.
42. Zhao F-Q., Keating A.F. Functional properties and genomics of glucose transporters. Curr Genomics 2007, 8:113-128.
43. Kahn B. Glucose transport: a pivotal step in insulin action. Diabetes 1996, 45:1644-1654.
44. Newsholme E., Dimitriadis G. Integration of biochemical and physiological effects of insulin on glucose metabolism. Exp Clin Endocrinol Diabetes 2001, 109(Suppl. 2):122-134.
45. Jacobs S.R., Rathmell J.C. Lymphocyte selection by starvation glucose metabolism and cell death. Trends Immunol 2006, 27:4-7.
46. Frauwirth K.A., Thompson C.B. Regulation of T lymphocyte metabolism. J Immunol 2004, 172:4661-4665.
47. Alberti K.G.M.M., Hockady T.D.R. Diabetic coma - a reappraisal after five years. Clin Endocrinol Metab 1977, 6:421-455.
48. Musa B.O.P., Onyemelukwe G.C., Hambolu J.O., Bakari A.G., Anumah F.E. Cell-mediated immunity in Type 2 diabetes mellitus patients in diabetic ketoacidosis, patients with controlled Type 2 diabetes mellitus and healthy control subjects. J Med Med Sci 2010, 1:290-295.
49. Knott R.M., Muckersie E., Robertson M., Forrester J.V. Glucose-dependent regulation of DNA synthesis in bovine retinal endothelial cells. Curr Eye Res 1998, 17:1-8.
50. Stentz F.B., Kitabchi A.E. Hyperglycemia-induced activation of human T-lymphocytes with de novo emergence of insulin receptors and generation of reactive oxygen species. Biochem Biophys Res Commun 2005, 335:491-495.